CA2441096C - Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques - Google Patents

Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques Download PDF

Info

Publication number
CA2441096C
CA2441096C CA002441096A CA2441096A CA2441096C CA 2441096 C CA2441096 C CA 2441096C CA 002441096 A CA002441096 A CA 002441096A CA 2441096 A CA2441096 A CA 2441096A CA 2441096 C CA2441096 C CA 2441096C
Authority
CA
Canada
Prior art keywords
nicotine
dmpp
cells
inflammatory
asthma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002441096A
Other languages
English (en)
Other versions
CA2441096A1 (fr
Inventor
Yvon Cormier
Evelyne Israel-Assayag
Marie-Renee Blanchet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Laval
Original Assignee
Universite Laval
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002341952A external-priority patent/CA2341952A1/fr
Application filed by Universite Laval filed Critical Universite Laval
Priority to CA002441096A priority Critical patent/CA2441096C/fr
Publication of CA2441096A1 publication Critical patent/CA2441096A1/fr
Application granted granted Critical
Publication of CA2441096C publication Critical patent/CA2441096C/fr
Priority to US13/178,670 priority patent/US8551983B2/en
Priority to US13/190,941 priority patent/US8557804B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne l'utilisation d'agonistes de récepteurs nicotiniques pour le traitement d'affections inflammatoires, y-compris des affections pulmonaires. De tels agonistes s'avèrent entraîner moins d'effets secondaires que d'autres anti-inflammatoires tels que les stéroïdes. En outre, ces agonistes peuvent s'utiliser seuls ou en association avec d'autres anti-inflammatoires pour soulager des affections pulmonaires.
CA002441096A 2001-03-23 2002-03-25 Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques Expired - Fee Related CA2441096C (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002441096A CA2441096C (fr) 2001-03-23 2002-03-25 Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques
US13/178,670 US8551983B2 (en) 2002-03-25 2011-07-08 Nicotinic receptor agonists for the treatment of inflammatory diseases
US13/190,941 US8557804B2 (en) 2002-03-25 2011-07-26 Nicotinic receptor agonists for the treatment of inflammatory diseases

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA002341952A CA2341952A1 (fr) 2001-03-23 2001-03-23 Agonistes du recepteur de la nicotine pour le traitement des maladies pulmonaires inflammatoires
CA2,341,952 2001-03-23
PCT/CA2002/000412 WO2002076434A2 (fr) 2001-03-23 2002-03-25 Traitement d'affections inflammatoires au moyen d'agonistes des récepteurs nicotiniques
CA002441096A CA2441096C (fr) 2001-03-23 2002-03-25 Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques

Publications (2)

Publication Number Publication Date
CA2441096A1 CA2441096A1 (fr) 2002-10-03
CA2441096C true CA2441096C (fr) 2009-06-30

Family

ID=29585104

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002441096A Expired - Fee Related CA2441096C (fr) 2001-03-23 2002-03-25 Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques

Country Status (1)

Country Link
CA (1) CA2441096C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2573977C (fr) * 2004-07-15 2012-04-10 Universite Laval Agonistes du recepteur de nicotine pour le traitement de maladies inflammatoires

Also Published As

Publication number Publication date
CA2441096A1 (fr) 2002-10-03

Similar Documents

Publication Publication Date Title
US8377936B2 (en) Nicotinic receptor agonists for the treatment of inflammatory diseases
US20070249622A1 (en) Nicotinic receptor agonists and analogues and derivatives thereof for the treatment of inflammatory diseases
AU2002249023A1 (en) Nicotinic receptor agonists for the treatment of inflammatory diseases
RU2414461C2 (ru) Агонисты рецепторов никотина и способы их применения для лечения воспалительных заболеваний
US20210393615A1 (en) Methods for treating neurological conditions and exposure to nerve agents
US20060142180A1 (en) Cholinergic modulation of microglial activation via alpha-7 nicotinic receptors
US8551983B2 (en) Nicotinic receptor agonists for the treatment of inflammatory diseases
CA2441096C (fr) Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques
US8557804B2 (en) Nicotinic receptor agonists for the treatment of inflammatory diseases

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160329